An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue - Related Studies

An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue

This study is currently recruiting participants.

Study NCT00678691. Last updated on September 17, 2008. Information provided by State University of New York - Upstate Medical University

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Fibromyalgia, Primary

2	Additional conditions recognized in this trial
		Fibromyalgia
		Myofascial Pain Syndromes

3	More general conditions related to this trial
		Muscular Diseases
		Musculoskeletal Diseases
		Nervous System Diseases
		Neuromuscular Diseases
		Rheumatic Diseases

4	Interventions listed in this trial
		armodafinil
		placebo

5	Additional drug interventions recognized in this trial
		Modafinil

6	More general drug interventions related to this trial
		Central Nervous System Agents
		Central Nervous System Stimulants
		Neuroprotective Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		State University of New York - Upstate Medical University